BRCA

Breast and prostate cancer are the most common malignancies in humans. Their prognosis depends on the time of diagnosis. Inherited mutations in BRCA1 and BRCA2 increase the risk of breast, ovarian and pancreatic cancers. In men, they increase the risk of prostate cancer. With Real Time PCR testing, we detect 8 BRCA gene mutations and enable accurate diagnosis for timely therapy.An indication for testing for BRCA gene mutations can also be a family history of cancer.